Roche plans to test if new medicine can prevent AD symptoms, Bloomberg says
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
7 hours ago
- Bloomberg
NASA's SpaceX Crew-10 Returns to Earth Successfully
NASA and SpaceX Crew-10 Mission to the International Space Station splashed-down to Earth successfully. The crew returns to Earth after a 5 month mission to the International Space Station. (Source: Bloomberg)
Yahoo
8 hours ago
- Yahoo
Study Finds Special Brain Traits of 'SuperAgers.' Here's How They Avoid Dementia
A study that began in the year 2000 is finally paying off. Northwestern University's SuperAger program has been in the works for over 25 years, and a new report in the Journal of the Alzheimer's Association is detailing what the group has found. Published on August 7, the report details the scope of the study and its results so far — 25 years out since the start. 290 people signed up to be studied in that time, all over 80 years old and cognitively well. Participants are tested for a high delayed word recall ability, signifying a higher memory capacity at an older age. These seniors that show exceptional memory are labeled "SuperAgers". Of the 290 participants, 79 allowed scientists to autopsy their brains after passing away. Because of this, researchers were able to make a connection between dementia, particularly Alzheimer's, and the structure of the brain. "Neurotypical seniors ≥ 80 years of age have significant and widespread cortical thinning compared to neurotypical 50- to 60-year-olds," the report reads, "Superagers, on the other hand, showed no cortical thinning compared to the younger controls." The brain — particularly the cerebral cortex — naturally thins as a person ages, but Northwestern's report shows that may happen less quickly in some people than in others. "It appears that cortical thinning is unavoidable," the report states, "but that it is probably much slower in superagers." Further, researchers reported that superagers' brains tend to develop few or zero amyloid plaques and tau tangles, which are two tell-tale signs of Alzheimer's disease. While no specific cause has been determined, researchers believe they're a bit closer to understanding dementia. What is dementia? Dementia is a decline in memory or mental capacity, usually found in senior citizens. Alzheimer's is the most common form of dementia, affecting around 11% of those 65 and older. There are various factors that scientists believe could lead to an increased chance of developing Alzheimer's or dementia as a person ages. Some of these factors, as found in the study by Northwestern University, are structural and genetic. Others, though, may come from a person's lifestyle. Research shows that traumatic brain injuries earlier in life, high blood pressure, untreated depression, and hearing loss may help onset dementia. Low physical activity and few meaningful personal connections may also exasperate the degenerative Finds Special Brain Traits of 'SuperAgers.' Here's How They Avoid Dementia first appeared on Men's Journal on Aug 7, 2025 Solve the daily Crossword
Bloomberg
12 hours ago
- Bloomberg
A Bitter Pill for Lab Firms as France Seeks to Cut Subsidies
Newsletter A report by a French agency is ringing alarm bells for investors and creditors who poured billions of euros into the medical labs sector. Welcome to The Brink. I'm Giulia Morpurgo, a reporter in London, where I have been looking into the headwinds that French private medical labs face. We also have the latest on bankrupt retailer Claire's, Altice Portugal's reorganization and Puerto Rico's bankruptcy. Follow this link to subscribe. Send us feedback and tips at debtnews@ It's an industry that's grown fat on public subsidies — and now the government is looking to pull them away. A report by a French agency is ringing alarm bells for investors and creditors who poured billions of euros into the medical labs sector.
